id	sid	eid	entity	type
ijpds-4503	1	1	saralaya & hiriyalu	ORG
ijpds-4503	1	2	3	CARDINAL
ijpds-4503	2	1	jan – mar	DATE
ijpds-4503	2	2	2024	CARDINAL
ijpds-4503	3	1	indian	NORP
ijpds-4503	3	2	j pharm drug	PRODUCT
ijpds-4503	3	3	8	CARDINAL
ijpds-4503	3	4	sukumar saralaya 1	ORG
ijpds-4503	3	5	hiriyalu2	PERSON
ijpds-4503	3	6	1assistant	CARDINAL
ijpds-4503	3	7	sri dharmasthala manjunatheshwara institute of technology	GPE
ijpds-4503	3	8	belthangady taluk	PERSON
ijpds-4503	3	9	dakshina kannada	PERSON
ijpds-4503	3	10	karnataka	GPE
ijpds-4503	3	11	2independent	CARDINAL
ijpds-4503	3	12	436	CARDINAL
ijpds-4503	3	13	jp nagar post	ORG
ijpds-4503	3	14	mysuru	GPE
ijpds-4503	3	15	karnataka	GPE
ijpds-4503	3	16	india	GPE
ijpds-4503	4	1	1	CARDINAL
ijpds-4503	6	1	1	CARDINAL
ijpds-4503	7	1	1	CARDINAL
ijpds-4503	7	2	1	CARDINAL
ijpds-4503	8	1	1	CARDINAL
ijpds-4503	9	1	1	CARDINAL
ijpds-4503	10	1	1	CARDINAL
ijpds-4503	11	1	lamotrigine	PERSON
ijpds-4503	12	1	1	CARDINAL
ijpds-4503	13	1	84057-84-1	DATE
ijpds-4503	13	2	256.09	CARDINAL
ijpds-4503	13	3	6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5diamine	QUANTITY
ijpds-4503	14	1	1	CARDINAL
ijpds-4503	15	1	at least 16 years of age or older	DATE
ijpds-4503	16	1	at least 18 years or older	DATE
ijpds-4503	17	1	2	CARDINAL
ijpds-4503	18	1	22nd feb 2024	DATE
ijpds-4503	18	2	27th feb 2024	DATE
ijpds-4503	18	3	04th	ORDINAL
ijpds-4503	18	4	3	CARDINAL
ijpds-4503	19	1	4	CARDINAL
ijpds-4503	20	1	first	ORDINAL
ijpds-4503	20	2	around 98%	PERCENT
ijpds-4503	20	3	5	CARDINAL
ijpds-4503	20	4	6	CARDINAL
ijpds-4503	21	1	1	CARDINAL
ijpds-4503	21	2	2-nglucuronide	QUANTITY
ijpds-4503	22	1	about 94%	PERCENT
ijpds-4503	22	2	around 2%	PERCENT
ijpds-4503	22	3	7	CARDINAL
ijpds-4503	22	4	8	CARDINAL
ijpds-4503	23	1	1	CARDINAL
ijpds-4503	24	1	1	CARDINAL
ijpds-4503	26	1	1	CARDINAL
ijpds-4503	76	1	sukumar saralaya	PERSON
ijpds-4503	76	2	sdm	ORG
ijpds-4503	76	3	siddhavana gurukula	PERSON
ijpds-4503	76	4	belthangady taluk	PERSON
ijpds-4503	76	5	dakshina kannada	PERSON
ijpds-4503	76	6	karnataka	GPE
ijpds-4503	76	7	india	GPE
ijpds-4503	76	8	574 240	CARDINAL
ijpds-4503	78	1	l mailto:sanjayss@sdmit.in saralaya &	ORG
ijpds-4503	78	2	3	CARDINAL
ijpds-4503	79	1	jan – mar	DATE
ijpds-4503	79	2	2024	CARDINAL
ijpds-4503	80	1	indian	NORP
ijpds-4503	80	2	j pharm drug	PRODUCT
ijpds-4503	80	3	9 1	CARDINAL
ijpds-4503	80	4	1	CARDINAL
ijpds-4503	80	5	1	CARDINAL
ijpds-4503	81	1	2,3dichlorobenzoic	CARDINAL
ijpds-4503	81	2	2	CARDINAL
ijpds-4503	81	3	1	CARDINAL
ijpds-4503	81	4	2,3	CARDINAL
ijpds-4503	81	5	3	CARDINAL
ijpds-4503	82	1	3	CARDINAL
ijpds-4503	82	2	1	CARDINAL
ijpds-4503	83	1	2e	CARDINAL
ijpds-4503	83	2	4	CARDINAL
ijpds-4503	83	3	1	CARDINAL
ijpds-4503	84	1	1,2dichloro-3	CARDINAL
ijpds-4503	84	2	5	CARDINAL
ijpds-4503	84	3	1	CARDINAL
ijpds-4503	85	1	one	CARDINAL
ijpds-4503	85	2	1,2-dichloro-3-nitrobenzene	QUANTITY
ijpds-4503	85	3	6	CARDINAL
ijpds-4503	85	4	1	CARDINAL
ijpds-4503	86	1	1	CARDINAL
ijpds-4503	86	2	3	CARDINAL
ijpds-4503	87	1	1	CARDINAL
ijpds-4503	87	2	1	CARDINAL
ijpds-4503	87	3	9	CARDINAL
ijpds-4503	88	1	3	CARDINAL
ijpds-4503	89	1	10	CARDINAL
ijpds-4503	90	1	1	CARDINAL
ijpds-4503	90	2	baxter mg	PERSON
ijpds-4503	91	1	11	CARDINAL
ijpds-4503	92	1	rees rw & russel pb	ORG
ijpds-4503	92	2	12	CARDINAL
ijpds-4503	96	1	n nh n nh nh2	ORG
ijpds-4503	96	2	4	CARDINAL
ijpds-4503	96	3	6	CARDINAL
ijpds-4503	96	4	1	CARDINAL
ijpds-4503	96	5	2	CARDINAL
ijpds-4503	96	6	1	CARDINAL
ijpds-4503	96	7	hitchings gh	PERSON
ijpds-4503	96	8	3,5-diamino	MONEY
ijpds-4503	97	1	3,4	CARDINAL
ijpds-4503	97	2	berghei	PERSON
ijpds-4503	98	1	13	CARDINAL
ijpds-4503	99	1	settepani ja	PERSON
ijpds-4503	99	2	2n	CARDINAL
ijpds-4503	99	3	14	CARDINAL
ijpds-4503	100	1	15-21	CARDINAL
ijpds-4503	101	1	roth	PERSON
ijpds-4503	101	2	3,5diamino-6	CARDINAL
ijpds-4503	101	3	22	CARDINAL
ijpds-4503	102	1	rees rwa	PERSON
ijpds-4503	102	2	7r	CARDINAL
ijpds-4503	103	1	aminoguanidine	PERSON
ijpds-4503	105	1	23	CARDINAL
ijpds-4503	106	1	24	CARDINAL
ijpds-4503	107	1	1	CARDINAL
ijpds-4503	107	2	25	CARDINAL
ijpds-4503	108	1	janes rw	PERSON
ijpds-4503	108	2	1	CARDINAL
ijpds-4503	108	3	30	CARDINAL
ijpds-4503	109	1	kerr dib	PERSON
ijpds-4503	109	2	3-methyl-6-[2(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazine 8	QUANTITY
ijpds-4503	109	3	31	CARDINAL
ijpds-4503	110	1	moreau	PERSON
ijpds-4503	110	2	1	CARDINAL
ijpds-4503	110	3	32	CARDINAL
ijpds-4503	111	1	messenheimer ja	PERSON
ijpds-4503	111	2	1	CARDINAL
ijpds-4503	112	1	33	CARDINAL
ijpds-4503	113	1	1	CARDINAL
ijpds-4503	113	2	1	CARDINAL
ijpds-4503	113	3	34	CARDINAL
ijpds-4503	114	1	janes aw	PERSON
ijpds-4503	114	2	6-(2	CARDINAL
ijpds-4503	114	3	9	CARDINAL
ijpds-4503	114	4	6-(2	CARDINAL
ijpds-4503	114	5	10	CARDINAL
ijpds-4503	114	6	6-(2	CARDINAL
ijpds-4503	114	7	11	CARDINAL
ijpds-4503	115	1	35	CARDINAL
ijpds-4503	116	1	sawyer da	PERSON
ijpds-4503	116	2	1i	CARDINAL
ijpds-4503	116	3	1	CARDINAL
ijpds-4503	116	4	1	CARDINAL
ijpds-4503	117	1	38	CARDINAL
ijpds-4503	118	1	potter b	PERSON
ijpds-4503	118	2	1i	CARDINAL
ijpds-4503	118	3	39	CARDINAL
ijpds-4503	119	1	willmore lj	PERSON
ijpds-4503	119	2	1	CARDINAL
ijpds-4503	119	3	40	CARDINAL
ijpds-4503	120	1	kubicki m	PERSON
ijpds-4503	120	2	1	CARDINAL
ijpds-4503	120	3	3	CARDINAL
ijpds-4503	120	4	jan – mar	DATE
ijpds-4503	120	5	2024	CARDINAL
ijpds-4503	120	6	indian	NORP
ijpds-4503	120	7	j pharm drug	PRODUCT
ijpds-4503	120	8	10 and 1	CARDINAL
ijpds-4503	120	9	41	CARDINAL
ijpds-4503	121	1	1	CARDINAL
ijpds-4503	122	1	12	CARDINAL
ijpds-4503	122	2	13	CARDINAL
ijpds-4503	123	1	42	CARDINAL
ijpds-4503	124	1	shridhar b	PERSON
ijpds-4503	124	2	1	CARDINAL
ijpds-4503	124	3	43-45	CARDINAL
ijpds-4503	125	1	6-aryl/6-hetaryl-7aminotetrazolo[1,5-b][1,2,4]triazines 14r	QUANTITY
ijpds-4503	125	2	6	CARDINAL
ijpds-4503	125	3	3,5diamino-1,2,4	CARDINAL
ijpds-4503	126	1	76.0%	PERCENT
ijpds-4503	126	2	1	CARDINAL
ijpds-4503	126	3	46	CARDINAL
ijpds-4503	127	1	7r	PRODUCT
ijpds-4503	128	1	f n	ORG
ijpds-4503	129	1	ch3oh	GPE
ijpds-4503	130	1	10	CARDINAL
ijpds-4503	131	1	2	CARDINAL
ijpds-4503	131	2	11	CARDINAL
ijpds-4503	133	1	n nh	ORG
ijpds-4503	135	1	12	CARDINAL
ijpds-4503	137	1	1	CARDINAL
ijpds-4503	137	2	2	CARDINAL
ijpds-4503	137	3	1	CARDINAL
ijpds-4503	137	4	23-46	CARDINAL
ijpds-4503	137	5	reddy vv	PERSON
ijpds-4503	137	6	3	CARDINAL
ijpds-4503	137	7	1	CARDINAL
ijpds-4503	137	8	f-j	ORG
ijpds-4503	138	1	47	CARDINAL
ijpds-4503	139	1	two	CARDINAL
ijpds-4503	139	2	1	CARDINAL
ijpds-4503	139	3	2-methyl,3amino,5	CARDINAL
ijpds-4503	139	4	15	CARDINAL
ijpds-4503	139	5	2-methyl,3,5-diamino-6-(2,3-dichlorophenyl)1,2,4-triazine	QUANTITY
ijpds-4503	139	6	hemi	GPE
ijpds-4503	139	7	16	CARDINAL
ijpds-4503	140	1	48	CARDINAL
ijpds-4503	141	1	two	CARDINAL
ijpds-4503	141	2	1	CARDINAL
ijpds-4503	141	3	3,5	CARDINAL
ijpds-4503	141	4	17	CARDINAL
ijpds-4503	141	5	3,5	CARDINAL
ijpds-4503	141	6	18	CARDINAL
ijpds-4503	142	1	49	CARDINAL
ijpds-4503	143	1	15	CARDINAL
ijpds-4503	144	1	16 n n n cl cl	QUANTITY
ijpds-4503	144	2	nh2 nh2	PERSON
ijpds-4503	144	3	17 n n n cl nh2 nh2	QUANTITY
ijpds-4503	144	4	18 n n n nh2 nh2	QUANTITY
ijpds-4503	144	5	3	CARDINAL
ijpds-4503	144	6	1	CARDINAL
ijpds-4503	144	7	47	CARDINAL
ijpds-4503	144	8	qian y. et al.	PERSON
ijpds-4503	144	9	1	CARDINAL
ijpds-4503	144	10	thirteen	CARDINAL
ijpds-4503	145	1	1	CARDINAL
ijpds-4503	145	2	1	CARDINAL
ijpds-4503	145	3	2,3	CARDINAL
ijpds-4503	145	4	19	CARDINAL
ijpds-4503	145	5	3	CARDINAL
ijpds-4503	146	1	3	CARDINAL
ijpds-4503	146	2	20	CARDINAL
ijpds-4503	146	3	methanesulfonic	GPE
ijpds-4503	146	4	dmf	PERSON
ijpds-4503	146	5	z)cyano(2,3-dichlorophenyl)methylidene]carbonohydrazonic	NORP
ijpds-4503	146	6	4a	CARDINAL
ijpds-4503	147	1	1	CARDINAL
ijpds-4503	148	1	21r	CARDINAL
ijpds-4503	148	2	1	CARDINAL
ijpds-4503	149	1	thirteen	CARDINAL
ijpds-4503	150	1	1	CARDINAL
ijpds-4503	150	2	gram	CARDINAL
ijpds-4503	151	1	gram	CARDINAL
ijpds-4503	151	2	50	CARDINAL
ijpds-4503	152	1	1	CARDINAL
ijpds-4503	152	2	51	CARDINAL
ijpds-4503	153	1	cheney	PERSON
ijpds-4503	153	2	ten	CARDINAL
ijpds-4503	153	3	1	CARDINAL
ijpds-4503	154	1	1	CARDINAL
ijpds-4503	154	2	1	CARDINAL
ijpds-4503	154	3	1	CARDINAL
ijpds-4503	154	4	1	CARDINAL
ijpds-4503	154	5	1	CARDINAL
ijpds-4503	154	6	1	CARDINAL
ijpds-4503	154	7	1	CARDINAL
ijpds-4503	154	8	1	CARDINAL
ijpds-4503	154	9	1	CARDINAL
ijpds-4503	154	10	1	CARDINAL
ijpds-4503	154	11	52	CARDINAL
ijpds-4503	155	1	razzaq sn	PERSON
ijpds-4503	155	2	3	CARDINAL
ijpds-4503	155	3	jan – mar	DATE
ijpds-4503	155	4	2024	CARDINAL
ijpds-4503	155	5	indian	NORP
ijpds-4503	155	6	j pharm drug	PRODUCT
ijpds-4503	155	7	11	CARDINAL
ijpds-4503	155	8	3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4	QUANTITY
ijpds-4503	155	9	22	CARDINAL
ijpds-4503	156	1	53	CARDINAL
ijpds-4503	157	1	1	CARDINAL
ijpds-4503	157	2	2	CARDINAL
ijpds-4503	157	3	3picoline	PRODUCT
ijpds-4503	158	1	1	CARDINAL
ijpds-4503	158	2	54	CARDINAL
ijpds-4503	159	1	chadha r	PERSON
ijpds-4503	159	2	1	CARDINAL
ijpds-4503	159	3	4-hydroxy	QUANTITY
ijpds-4503	160	1	55	CARDINAL
ijpds-4503	161	1	rao sn	PERSON
ijpds-4503	161	2	five	CARDINAL
ijpds-4503	161	3	1	CARDINAL
ijpds-4503	162	1	2-(2,3-dichlorophenyl)-2-(guanidinylimino	QUANTITY
ijpds-4503	163	1	4	CARDINAL
ijpds-4503	163	2	23	CARDINAL
ijpds-4503	163	3	25	CARDINAL
ijpds-4503	163	4	3,5-bis-(2,3-dichloro-benzamido)6-(2,3-dichloro-phenyl)-1,2,4-triazine	QUANTITY
ijpds-4503	163	5	26	CARDINAL
ijpds-4503	164	1	23	CARDINAL
ijpds-4503	164	2	26	CARDINAL
ijpds-4503	164	3	56	CARDINAL
ijpds-4503	165	1	ki mono-chlorobenzene	PERSON
ijpds-4503	165	2	70%	PERCENT
ijpds-4503	165	3	39.1%	PERCENT
ijpds-4503	165	4	nh2 nh nh nh2 .hcl	ORG
ijpds-4503	166	1	4a	CARDINAL
ijpds-4503	166	2	koh	PERSON
ijpds-4503	166	3	h2o80	PERSON
ijpds-4503	166	4	1	CARDINAL
ijpds-4503	166	5	clcl n o h	ORG
ijpds-4503	167	1	nh2 clcl n n h nh nh2	PERSON
ijpds-4503	167	2	24 cl cl	QUANTITY
ijpds-4503	168	1	25 cl cl	QUANTITY
ijpds-4503	169	1	26 cl cl	QUANTITY
ijpds-4503	171	1	oh o	DATE
ijpds-4503	177	1	22	CARDINAL
ijpds-4503	177	2	4	CARDINAL
ijpds-4503	177	3	1	CARDINAL
ijpds-4503	177	4	53-56	CARDINAL
ijpds-4503	177	5	four	CARDINAL
ijpds-4503	177	6	1	CARDINAL
ijpds-4503	177	7	dmf	PERSON
ijpds-4503	177	8	3	CARDINAL
ijpds-4503	178	1	57	CARDINAL
ijpds-4503	179	1	1	CARDINAL
ijpds-4503	179	2	venkanna	CARDINAL
ijpds-4503	179	3	2	CARDINAL
ijpds-4503	180	1	4a	CARDINAL
ijpds-4503	181	1	3-amino-6-(2,3dichlorophenyl)-1,2,4-	QUANTITY
ijpds-4503	181	2	27	CARDINAL
ijpds-4503	182	1	6-(2,3	CARDINAL
ijpds-4503	182	2	28	CARDINAL
ijpds-4503	183	1	58	CARDINAL
ijpds-4503	184	1	3	CARDINAL
ijpds-4503	184	2	jan – mar	DATE
ijpds-4503	184	3	2024	CARDINAL
ijpds-4503	184	4	indian	NORP
ijpds-4503	184	5	j pharm drug	PRODUCT
ijpds-4503	184	6	12 cl cl	QUANTITY
ijpds-4503	184	7	o	DATE
ijpds-4503	184	8	27 4a 1 cl cl	QUANTITY
ijpds-4503	184	9	28	CARDINAL
ijpds-4503	184	10	0.1n	CARDINAL
ijpds-4503	184	11	3	CARDINAL
ijpds-4503	184	12	activ	PERSON
ijpds-4503	184	13	3	CARDINAL
ijpds-4503	184	14	activ	PERSON
ijpds-4503	184	15	94%	PERCENT
ijpds-4503	184	16	84%	PERCENT
ijpds-4503	184	17	86%	PERCENT
ijpds-4503	185	1	80%	PERCENT
ijpds-4503	185	2	2	CARDINAL
ijpds-4503	185	3	1 and 28	CARDINAL
ijpds-4503	186	1	chadha r	PERSON
ijpds-4503	186	2	four	CARDINAL
ijpds-4503	186	3	1	CARDINAL
ijpds-4503	187	1	59	CARDINAL
ijpds-4503	188	1	1	CARDINAL
ijpds-4503	189	1	60	CARDINAL
ijpds-4503	190	1	leitch dc	GPE
ijpds-4503	190	2	3	CARDINAL
ijpds-4503	191	1	77%	PERCENT
ijpds-4503	192	1	61	CARDINAL
ijpds-4503	193	1	two	CARDINAL
ijpds-4503	193	2	1	CARDINAL
ijpds-4503	193	3	4,4′bipyridine	CARDINAL
ijpds-4503	193	4	2,2′-bipyridine	CARDINAL
ijpds-4503	194	1	62	CARDINAL
ijpds-4503	195	1	kaur r	PERSON
ijpds-4503	195	2	two	CARDINAL
ijpds-4503	195	3	1	CARDINAL
ijpds-4503	196	1	63	CARDINAL
ijpds-4503	197	1	makki m	PERSON
ijpds-4503	197	2	1	CARDINAL
ijpds-4503	197	3	64	CARDINAL
ijpds-4503	198	1	kitson pj	PERSON
ijpds-4503	198	2	1	CARDINAL
ijpds-4503	199	1	250 mg	QUANTITY
ijpds-4503	199	2	3	CARDINAL
ijpds-4503	199	3	1	CARDINAL
ijpds-4503	199	4	two	CARDINAL
ijpds-4503	199	5	112 mg	QUANTITY
ijpds-4503	199	6	46%	PERCENT
ijpds-4503	200	1	65	CARDINAL
ijpds-4503	201	1	matias m	PERSON
ijpds-4503	201	2	1	CARDINAL
ijpds-4503	201	3	66	CARDINAL
ijpds-4503	202	1	kuang wj	PERSON
ijpds-4503	202	2	two	CARDINAL
ijpds-4503	202	3	1	CARDINAL
ijpds-4503	203	1	1	CARDINAL
ijpds-4503	203	2	1	CARDINAL
ijpds-4503	204	1	1	CARDINAL
ijpds-4503	204	2	67	CARDINAL
ijpds-4503	205	1	kuang w	PERSON
ijpds-4503	205	2	1	CARDINAL
ijpds-4503	205	3	1,2,3,6	CARDINAL
ijpds-4503	205	4	4	CARDINAL
ijpds-4503	205	5	68	CARDINAL
ijpds-4503	206	1	heravi mm	PERSON
ijpds-4503	206	2	69	CARDINAL
ijpds-4503	207	1	satapathy bs	PERSON
ijpds-4503	207	2	1	CARDINAL
ijpds-4503	208	1	1	CARDINAL
ijpds-4503	208	2	70	CARDINAL
ijpds-4503	209	1	1	CARDINAL
ijpds-4503	209	2	4hydroxy	CARDINAL
ijpds-4503	210	1	71	CARDINAL
ijpds-4503	211	1	li j	PERSON
ijpds-4503	211	2	two	CARDINAL
ijpds-4503	211	3	two	CARDINAL
ijpds-4503	211	4	1	CARDINAL
ijpds-4503	211	5	72	CARDINAL
ijpds-4503	212	1	1	CARDINAL
ijpds-4503	212	2	73-75	CARDINAL
ijpds-4503	213	1	1	CARDINAL
ijpds-4503	214	1	9	CARDINAL
ijpds-4503	215	1	1	CARDINAL
ijpds-4503	216	1	1	CARDINAL
ijpds-4503	217	1	1	CARDINAL
ijpds-4503	218	1	1	CARDINAL
ijpds-4503	218	2	google	ORG
ijpds-4503	218	3	uspto	ORG
ijpds-4503	218	4	united states	ORG
ijpds-4503	218	5	european	NORP
ijpds-4503	219	1	1	CARDINAL
ijpds-4503	221	1	1	CARDINAL
ijpds-4503	222	1	1	CARDINAL
ijpds-4503	223	1	saralaya &	ORG
ijpds-4503	223	2	3	CARDINAL
ijpds-4503	223	3	jan – mar	DATE
ijpds-4503	223	4	2024	CARDINAL
ijpds-4503	223	5	indian	NORP
ijpds-4503	223	6	j pharm drug	PRODUCT
ijpds-4503	223	7	13	CARDINAL
ijpds-4503	223	8	1	CARDINAL
ijpds-4503	224	1	ks	GPE
ijpds-4503	224	2	poovanpallil nb	PERSON
ijpds-4503	224	3	bhatt lk	PERSON
ijpds-4503	226	1	2015;6	CARDINAL
ijpds-4503	228	1	2	CARDINAL
ijpds-4503	228	2	gilad r. lamotrigine	PERSON
ijpds-4503	229	1	behav	PERSON
ijpds-4503	230	1	2016	CARDINAL
ijpds-4503	230	2	6(3	CARDINAL
ijpds-4503	232	1	3. goa kl	TIME
ijpds-4503	232	2	ross sr	PERSON
ijpds-4503	234	1	1993	DATE
ijpds-4503	234	2	46(1):152–76	DATE
ijpds-4503	235	1	4	CARDINAL
ijpds-4503	235	2	dibué-adjei	PERSON
ijpds-4503	235	3	kamp ma	PERSON
ijpds-4503	235	4	alpdogan s	PERSON
ijpds-4503	237	1	physiol biochem	ORG
ijpds-4503	238	1	2017	CARDINAL
ijpds-4503	238	2	44(3):935–47	DATE
ijpds-4503	239	1	5	CARDINAL
ijpds-4503	239	2	rambeck	PERSON
ijpds-4503	239	3	wolf p. lamotrigine	PERSON
ijpds-4503	240	1	clin pharmacokinet	PERSON
ijpds-4503	240	2	1993	DATE
ijpds-4503	240	3	25(6):433–43	CARDINAL
ijpds-4503	241	1	6	CARDINAL
ijpds-4503	241	2	methaneethorn j	PERSON
ijpds-4503	243	1	2020	DATE
ijpds-4503	243	2	82:133–47	CARDINAL
ijpds-4503	244	1	7	CARDINAL
ijpds-4503	244	2	patsalos	PERSON
ijpds-4503	244	3	lamotrigine	PERSON
ijpds-4503	248	1	2022	CARDINAL
ijpds-4503	249	1	https://doi.org/10.1007/978-3-030-827908_16	PRODUCT
ijpds-4503	249	2	8	CARDINAL
ijpds-4503	250	1	farhan m	PERSON
ijpds-4503	250	2	rani p	PERSON
ijpds-4503	251	1	moledina f	PERSON
ijpds-4503	252	1	j pharmacol pharmacother	PERSON
ijpds-4503	253	1	2022	CARDINAL
ijpds-4503	253	2	13(2):160	CARDINAL
ijpds-4503	253	3	6	CARDINAL
ijpds-4503	253	4	9	CARDINAL
ijpds-4503	253	5	saralaya ss	PERSON
ijpds-4503	254	1	lamotrigine	PRODUCT
ijpds-4503	255	1	mediterr j pharm pharm sci	ORG
ijpds-4503	256	1	4(1):52-74	DATE
ijpds-4503	257	1	10	CARDINAL
ijpds-4503	257	2	wellcome foundation	ORG
ijpds-4503	259	1	759014	DATE
ijpds-4503	259	2	1956	DATE
ijpds-4503	260	1	11	CARDINAL
ijpds-4503	261	1	baxter mg	PERSON
ijpds-4503	261	2	miller aa	PERSON
ijpds-4503	263	1	european	NORP
ijpds-4503	264	1	1981	DATE
ijpds-4503	266	1	12	CARDINAL
ijpds-4503	267	1	rees rw	PERSON
ijpds-4503	267	2	russell pb	PERSON
ijpds-4503	268	1	6-(fluoro	CARDINAL
ijpds-4503	269	1	us	GPE
ijpds-4503	269	2	3637688	DATE
ijpds-4503	269	3	1972	DATE
ijpds-4503	270	1	https://patents.google.com/patent/us3637688a/en	CARDINAL
ijpds-4503	270	2	13	CARDINAL
ijpds-4503	271	1	hitchings gh	PERSON
ijpds-4503	271	2	russell pb	PERSON
ijpds-4503	274	1	1952;74(12):3200–1	CARDINAL
ijpds-4503	275	1	14	CARDINAL
ijpds-4503	276	1	settepani ja	PERSON
ijpds-4503	276	2	bořkovec ab	PERSON
ijpds-4503	277	1	3,5-diamino-	MONEY
ijpds-4503	279	1	1966	DATE
ijpds-4503	280	1	3(2):188–90	CARDINAL
ijpds-4503	281	1	15	CARDINAL
ijpds-4503	281	2	bořkovec ab	PERSON
ijpds-4503	283	1	new york	GPE
ijpds-4503	283	2	ny	GPE
ijpds-4503	283	3	springer new york	ORG
ijpds-4503	283	4	1964	DATE
ijpds-4503	283	5	87	CARDINAL
ijpds-4503	284	1	16	CARDINAL
ijpds-4503	285	1	schroeder h	ORG
ijpds-4503	287	1	1958	DATE
ijpds-4503	288	1	23(10):1522–4	CARDINAL
ijpds-4503	289	1	17	CARDINAL
ijpds-4503	289	2	falco ea	PERSON
ijpds-4503	289	3	pappas e	PERSON
ijpds-4503	289	4	hitchings gh	PERSON
ijpds-4503	291	1	1956;78(9):1938–41.	DATE
ijpds-4503	292	1	18	CARDINAL
ijpds-4503	293	1	beyer h	ORG
ijpds-4503	293	2	pyl t	GPE
ijpds-4503	293	3	wünsch k-h.	PERSON
ijpds-4503	294	1	1960	DATE
ijpds-4503	294	2	93(10):2209–16	CARDINAL
ijpds-4503	295	1	19	CARDINAL
ijpds-4503	297	1	angewandte chemie	ORG
ijpds-4503	297	2	1954	DATE
ijpds-4503	297	3	66(19):605–605	CARDINAL
ijpds-4503	299	1	fusco r	PERSON
ijpds-4503	299	2	rossi s. asymmetric triazines	PERSON
ijpds-4503	299	3	tetrahedron	ORG
ijpds-4503	300	1	1958	DATE
ijpds-4503	300	2	3(3):209–24	DATE
ijpds-4503	301	1	21	CARDINAL
ijpds-4503	302	1	weisgerber ga	PERSON
ijpds-4503	302	2	benzoyl cyanide	PERSON
ijpds-4503	304	1	1944	DATE
ijpds-4503	304	2	24:14.	DATE
ijpds-4503	305	1	22	CARDINAL
ijpds-4503	306	1	roth	PERSON
ijpds-4503	306	2	strelitz jz	PERSON
ijpds-4503	306	3	protonation	ORG
ijpds-4503	306	4	2,4	CARDINAL
ijpds-4503	309	1	1969	DATE
ijpds-4503	310	1	34(4):821–36	CARDINAL
ijpds-4503	311	1	23	CARDINAL
ijpds-4503	312	1	rees rw	PERSON
ijpds-4503	312	2	russell pb	PERSON
ijpds-4503	312	3	foell tj	PERSON
ijpds-4503	313	1	some 3,5-diamino-as	CARDINAL
ijpds-4503	315	1	1972	DATE
ijpds-4503	315	2	15(8):859–61	DATE
ijpds-4503	316	1	24	CARDINAL
ijpds-4503	316	2	bajwa gs	PERSON
ijpds-4503	316	3	lee j	PERSON
ijpds-4503	317	1	3. 1,2,4triazines	CARDINAL
ijpds-4503	319	1	1976	DATE
ijpds-4503	320	1	19(6):845–8	CARDINAL
ijpds-4503	320	2	25	CARDINAL
ijpds-4503	320	3	marden cm	PERSON
ijpds-4503	320	4	miller aa.	PERSON
ijpds-4503	321	1	neurochemical	ORG
ijpds-4503	323	1	1986	DATE
ijpds-4503	324	1	27(5):490–7	DATE
ijpds-4503	325	1	26	CARDINAL
ijpds-4503	326	1	miller aa	PERSON
ijpds-4503	326	2	wheatley p	PERSON
ijpds-4503	326	3	sawyer da	PERSON
ijpds-4503	326	4	i.	PERSON
ijpds-4503	328	1	1986;27(5):483–9	CARDINAL
ijpds-4503	329	1	27	CARDINAL
ijpds-4503	330	1	jawad s	PERSON
ijpds-4503	330	2	yuen wc	PERSON
ijpds-4503	333	1	j clin pharmacol	PERSON
ijpds-4503	334	1	1986	DATE
ijpds-4503	335	1	22(2):191–3	CARDINAL
ijpds-4503	337	1	binnie	PERSON
ijpds-4503	337	2	rmc	ORG
ijpds-4503	337	3	lamotrigine	PRODUCT
ijpds-4503	339	1	1989;4(3):222–9. 29	CARDINAL
ijpds-4503	340	1	brodie mj	PERSON
ijpds-4503	340	2	lamotrigine	PERSON
ijpds-4503	341	1	lancet	ORG
ijpds-4503	342	1	1992	DATE
ijpds-4503	342	2	339(8806):1397–400	CARDINAL
ijpds-4503	342	3	30	CARDINAL
ijpds-4503	343	1	janes rw	PERSON
ijpds-4503	343	2	lisgarten jn	PERSON
ijpds-4503	343	3	3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4triazine	QUANTITY
ijpds-4503	344	1	c. 1989	DATE
ijpds-4503	344	2	45(1):129–32	CARDINAL
ijpds-4503	345	1	kerr dib	PERSON
ijpds-4503	345	2	ong j. gaba	PERSON
ijpds-4503	346	1	1992	DATE
ijpds-4503	346	2	12(6):593–636	CARDINAL
ijpds-4503	346	3	32	CARDINAL
ijpds-4503	347	1	moreau s	PERSON
ijpds-4503	347	2	coudert p	PERSON
ijpds-4503	348	1	1994	DATE
ijpds-4503	348	2	37(14):2153–60	CARDINAL
ijpds-4503	348	3	33	CARDINAL
ijpds-4503	349	1	messenheimer ja.	PERSON
ijpds-4503	349	2	lamotrigine	PERSON
ijpds-4503	350	1	epilepsia	PERSON
ijpds-4503	351	1	1995	DATE
ijpds-4503	351	2	36(2):s87-94	CARDINAL
ijpds-4503	352	1	34	CARDINAL
ijpds-4503	352	2	dickins m	PERSON
ijpds-4503	352	3	sawyer da	PERSON
ijpds-4503	352	4	moreley tj	PERSON
ijpds-4503	353	1	lamotrigine	PERSON
ijpds-4503	354	1	levy rh	PERSON
ijpds-4503	354	2	mattson rh	PERSON
ijpds-4503	354	3	meldrum bs	PERSON
ijpds-4503	356	1	5th	ORDINAL
ijpds-4503	357	1	new york	GPE
ijpds-4503	357	2	raven press	ORG
ijpds-4503	357	3	1995	DATE
ijpds-4503	357	4	35	CARDINAL
ijpds-4503	358	1	janes rw	PERSON
ijpds-4503	359	1	3,5-diamino-6(2-fluorophenyl)-1,2,4	CARDINAL
ijpds-4503	360	1	c. 1995	GPE
ijpds-4503	360	2	51(3):440–2	CARDINAL
ijpds-4503	360	3	36	CARDINAL
ijpds-4503	361	1	janes rw	PERSON
ijpds-4503	362	1	3,5	CARDINAL
ijpds-4503	363	1	c. 1995	GPE
ijpds-4503	363	2	51(4):685–8	CARDINAL
ijpds-4503	363	3	37	DATE
ijpds-4503	364	1	janes rw	PERSON
ijpds-4503	365	1	3,5	CARDINAL
ijpds-4503	366	1	c. 1996	GPE
ijpds-4503	367	1	52(10):2627–9	CARDINAL
ijpds-4503	368	1	38	CARDINAL
ijpds-4503	369	1	sawyer da	PERSON
ijpds-4503	369	2	triazine salt	PERSON
ijpds-4503	369	3	0247892	DATE
ijpds-4503	369	4	1991	DATE
ijpds-4503	370	1	https://patents.google.com/patent/ep0247892b1/en	ORDINAL
ijpds-4503	372	1	https://doi.org/10.1007/978-3-030-827908_16	PERSON
ijpds-4503	373	1	3	CARDINAL
ijpds-4503	373	2	jan – mar	DATE
ijpds-4503	373	3	2024	CARDINAL
ijpds-4503	373	4	indian	NORP
ijpds-4503	373	5	j pharm drug	PRODUCT
ijpds-4503	373	6	14 39	DATE
ijpds-4503	374	1	potter b	PERSON
ijpds-4503	375	1	1999	DATE
ijpds-4503	375	2	29(6):701–6	CARDINAL
ijpds-4503	375	3	40	CARDINAL
ijpds-4503	376	1	willmore lj	PERSON
ijpds-4503	376	2	lamotrigine	PERSON
ijpds-4503	377	1	rev neurother	PERSON
ijpds-4503	378	1	2001	DATE
ijpds-4503	378	2	1(1):33	CARDINAL
ijpds-4503	378	3	42	CARDINAL
ijpds-4503	378	4	41	CARDINAL
ijpds-4503	379	1	kubicki m	PERSON
ijpds-4503	379	2	3,5diamino-6	CARDINAL
ijpds-4503	381	1	2001	DATE
ijpds-4503	382	1	570(1–3):53–60	CARDINAL
ijpds-4503	382	2	42	CARDINAL
ijpds-4503	383	1	slouka j	PERSON
ijpds-4503	385	1	2003	DATE
ijpds-4503	385	2	1:22–8	DATE
ijpds-4503	386	1	43	CARDINAL
ijpds-4503	387	1	ravikumar k. lamotriginium benzoate	PERSON
ijpds-4503	389	1	2005	DATE
ijpds-4503	389	2	61(11):o3805–7	CARDINAL
ijpds-4503	389	3	44	DATE
ijpds-4503	390	1	ravikumar k. lamotrigine	PERSON
ijpds-4503	392	1	2006	DATE
ijpds-4503	393	1	62(10):o4752–4	CARDINAL
ijpds-4503	393	2	45	CARDINAL
ijpds-4503	393	3	ravikumar k. crystal	PERSON
ijpds-4503	393	4	1:1:1	CARDINAL
ijpds-4503	394	1	mol cryst liq cryst	PERSON
ijpds-4503	395	1	2006	DATE
ijpds-4503	395	2	461(1):131–41	CARDINAL
ijpds-4503	396	1	46	DATE
ijpds-4503	397	1	deev sl	PERSON
ijpds-4503	399	1	russ chem bull	ORG
ijpds-4503	400	1	2005	DATE
ijpds-4503	401	1	54(3):726–32	CARDINAL
ijpds-4503	402	1	47	CARDINAL
ijpds-4503	403	1	reddy vv	PERSON
ijpds-4503	405	1	2008	DATE
ijpds-4503	406	1	48	DATE
ijpds-4503	407	1	palmer ra	PERSON
ijpds-4503	407	2	potter bs	PERSON
ijpds-4503	408	1	two	CARDINAL
ijpds-4503	408	2	2-methyl,3-amino	TIME
ijpds-4503	408	3	5	CARDINAL
ijpds-4503	408	4	2-methyl,3,5-diamino-6-(2,3dichlorophenyl)-1,2,4-triazine	QUANTITY
ijpds-4503	408	5	hemi	GPE
ijpds-4503	409	1	2008	DATE
ijpds-4503	410	1	38(4):255–60	CARDINAL
ijpds-4503	410	2	49	CARDINAL
ijpds-4503	411	1	palmer ra	PERSON
ijpds-4503	411	2	potter bs	PERSON
ijpds-4503	412	1	two	CARDINAL
ijpds-4503	412	2	3,5	CARDINAL
ijpds-4503	413	1	2008	DATE
ijpds-4503	413	2	38(5):387–92	CARDINAL
ijpds-4503	414	1	50	CARDINAL
ijpds-4503	415	1	qian y, lv p	PERSON
ijpds-4503	416	1	bangalore	GPE
ijpds-4503	417	1	2009	DATE
ijpds-4503	417	2	121(4):463–70	CARDINAL
ijpds-4503	418	1	51	CARDINAL
ijpds-4503	418	2	ravikumar k. lamotrigine	PERSON
ijpds-4503	419	1	c. 2009	PERSON
ijpds-4503	420	1	65(9):o460–4	CARDINAL
ijpds-4503	422	1	cheney ml	PERSON
ijpds-4503	422	2	lamotrigine	ORG
ijpds-4503	423	1	cryst growth des.	ORG
ijpds-4503	423	2	2010	DATE
ijpds-4503	424	1	10(1):394–405	DATE
ijpds-4503	425	1	53	DATE
ijpds-4503	426	1	razzaq sn	PERSON
ijpds-4503	426	2	khan iu	PERSON
ijpds-4503	426	3	şahin o	GPE
ijpds-4503	426	4	lamotriginium dihydrogen phosphate–4-(dimethylamino)benzaldehyde	PERSON
ijpds-4503	426	5	1/1	CARDINAL
ijpds-4503	428	1	2010	DATE
ijpds-4503	428	2	66(10):o2558	CARDINAL
ijpds-4503	429	1	54	CARDINAL
ijpds-4503	430	1	ravikumar k. crystal	PERSON
ijpds-4503	430	2	2	CARDINAL
ijpds-4503	430	3	3-picoline	QUANTITY
ijpds-4503	432	1	2011	DATE
ijpds-4503	433	1	41(9):1289–300	CARDINAL
ijpds-4503	435	1	chadha r	PERSON
ijpds-4503	435	2	arora p	ORG
ijpds-4503	437	1	2011	DATE
ijpds-4503	437	2	13(20):6271	CARDINAL
ijpds-4503	438	1	56	CARDINAL
ijpds-4503	438	2	rao sn	PERSON
ijpds-4503	439	1	archive.org	ORG
ijpds-4503	439	2	2012	DATE
ijpds-4503	440	1	57	CARDINAL
ijpds-4503	441	1	meštrović e. cocrystals	PERSON
ijpds-4503	442	1	cryst growth des	ORG
ijpds-4503	442	2	2012	DATE
ijpds-4503	443	1	12(4):1847–58	CARDINAL
ijpds-4503	444	1	58	CARDINAL
ijpds-4503	445	1	venkanna	CARDINAL
ijpds-4503	445	2	6-(2	CARDINAL
ijpds-4503	445	3	3	CARDINAL
ijpds-4503	445	4	2	CARDINAL
ijpds-4503	445	5	4	CARDINAL
ijpds-4503	445	6	3,5diamine(lamotrigine	CARDINAL
ijpds-4503	447	1	2012	DATE
ijpds-4503	447	2	4(1):100–5	CARDINAL
ijpds-4503	448	1	59	CARDINAL
ijpds-4503	449	1	chadha r	PERSON
ijpds-4503	449	2	four	CARDINAL
ijpds-4503	450	1	cryst growth des.	ORG
ijpds-4503	450	2	2013	DATE
ijpds-4503	450	3	13(2):858–70	CARDINAL
ijpds-4503	451	1	60	CARDINAL
ijpds-4503	452	1	liu	PERSON
ijpds-4503	452	2	lamotrigine	ORG
ijpds-4503	453	1	environ sci process impacts	ORG
ijpds-4503	454	1	2014	DATE
ijpds-4503	455	1	16(4):848–57	CARDINAL
ijpds-4503	456	1	61	CARDINAL
ijpds-4503	457	1	leitch dc	GPE
ijpds-4503	457	2	john mp	PERSON
ijpds-4503	458	1	2,3	CARDINAL
ijpds-4503	458	2	lamotrigine	PRODUCT
ijpds-4503	459	1	2017	CARDINAL
ijpds-4503	459	2	21(11):1815–21	CARDINAL
ijpds-4503	460	1	62	CARDINAL
ijpds-4503	461	1	du s	PERSON
ijpds-4503	461	2	wang y	PERSON
ijpds-4503	461	3	wu s	PERSON
ijpds-4503	462	1	two	CARDINAL
ijpds-4503	463	1	eur j pharm sci	ORG
ijpds-4503	463	2	2017	CARDINAL
ijpds-4503	463	3	110:19–25	CARDINAL
ijpds-4503	464	1	kaur r	PERSON
ijpds-4503	464	2	cavanagh kl	PERSON
ijpds-4503	466	1	cryst growth des.	ORG
ijpds-4503	466	2	2017	CARDINAL
ijpds-4503	466	3	17(10):5012–6	CARDINAL
ijpds-4503	467	1	64	CARDINAL
ijpds-4503	468	1	makki m	PERSON
ijpds-4503	468	2	bakhotmah da	PERSON
ijpds-4503	468	3	abdel-rahman rm	PERSON
ijpds-4503	470	1	curr org synth	ORG
ijpds-4503	471	1	2018	DATE
ijpds-4503	471	2	15(1):116–25.	DATE
ijpds-4503	473	1	kitson pj	PERSON
ijpds-4503	473	2	marie g	PERSON
ijpds-4503	473	3	francoia	ORG
ijpds-4503	474	1	sci. 2018	ORG
ijpds-4503	474	2	359(6373):314-9	CARDINAL
ijpds-4503	474	3	66	CARDINAL
ijpds-4503	475	1	matias m.	PERSON
ijpds-4503	476	1	2018	DATE
ijpds-4503	477	1	kuang wj	PERSON
ijpds-4503	477	2	ji sc	ORG
ijpds-4503	480	1	cryst growth des.	ORG
ijpds-4503	480	2	2019	DATE
ijpds-4503	481	1	19(11):6603–10	CARDINAL
ijpds-4503	482	1	68	CARDINAL
ijpds-4503	483	1	kuang w	PERSON
ijpds-4503	483	2	ji s	ORG
ijpds-4503	483	3	wei y	PERSON
ijpds-4503	484	1	1	CARDINAL
ijpds-4503	484	2	1	CARDINAL
ijpds-4503	484	3	1,2,3,6	CARDINAL
ijpds-4503	485	1	cryst eng	PERSON
ijpds-4503	486	1	2020	DATE
ijpds-4503	487	1	22(15):2681–8	CARDINAL
ijpds-4503	488	1	69	CARDINAL
ijpds-4503	489	1	heravi mm	PERSON
ijpds-4503	489	2	zadsirjan v. prescribed drugs	PERSON
ijpds-4503	490	1	rsc adv.	PERSON
ijpds-4503	490	2	2020	DATE
ijpds-4503	491	1	10(72):44247–311	CARDINAL
ijpds-4503	492	1	70	CARDINAL
ijpds-4503	493	1	satapathy bs	PERSON
ijpds-4503	493	2	sahoo rn	FAC
ijpds-4503	495	1	serb	NORP
ijpds-4503	495	2	2021	CARDINAL
ijpds-4503	495	3	71	CARDINAL
ijpds-4503	496	1	chimakurthy j	PERSON
ijpds-4503	496	2	palei nn	PERSON
ijpds-4503	497	1	negat	ORG
ijpds-4503	498	1	2022	CARDINAL
ijpds-4503	499	1	622–33	CARDINAL
ijpds-4503	499	2	72	DATE
ijpds-4503	500	1	li j	PERSON
ijpds-4503	500	2	huang y	PERSON
ijpds-4503	500	3	two	CARDINAL
ijpds-4503	500	4	two	CARDINAL
ijpds-4503	502	1	2022	CARDINAL
ijpds-4503	502	2	628(122310):122310.	DATE
ijpds-4503	504	1	kumar r	PERSON
ijpds-4503	504	2	kumar n	PERSON
ijpds-4503	504	3	roy r	PERSON
ijpds-4503	505	1	curr med drug res	ORG
ijpds-4503	505	2	2017	CARDINAL
ijpds-4503	506	1	https://oa.mg/work/2805517906 saralaya &	ORG
ijpds-4503	506	2	3	CARDINAL
ijpds-4503	507	1	jan – mar	DATE
ijpds-4503	507	2	2024	CARDINAL
ijpds-4503	507	3	indian	NORP
ijpds-4503	507	4	j pharm drug	PRODUCT
ijpds-4503	507	5	15	CARDINAL
ijpds-4503	509	1	majid a	PERSON
ijpds-4503	509	2	lawal am	PERSON
ijpds-4503	509	3	ashid m	PERSON
ijpds-4503	510	1	1	CARDINAL
ijpds-4503	510	2	2	DATE
ijpds-4503	510	3	4	CARDINAL
ijpds-4503	511	1	journal of indian research	ORG
ijpds-4503	512	1	2020	DATE
ijpds-4503	512	2	8(1):37-52	ORG
ijpds-4503	513	1	75	CARDINAL
ijpds-4503	514	1	yaduwanshi ps	PERSON
ijpds-4503	514	2	agrawal o	PERSON
ijpds-4503	514	3	mishra mk	PERSON
ijpds-4503	515	1	quinazolinone	GPE
ijpds-4503	516	1	nat	ORG
ijpds-4503	517	1	2021	CARDINAL
ijpds-4503	518	1	5257–74	CARDINAL
ijpds-4503	519	1	saralaya ss	PERSON
ijpds-4503	521	1	indian	NORP
ijpds-4503	521	2	2024	CARDINAL
ijpds-4503	521	3	3(1):8-15	DATE